4D Molecular Therapeutics Overview
4D Molecular Therapeutics Target Price
Analysts' 12-month price predictions for FDMT.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.01
Average Target Price
$33.00
229.7% upside
229.7% upside1 analysts in the last 4 months
High: $33 | Low: $33
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-08 | Goldman Sachs | $33 | 229.7% upside |  |
| 2025-11-11 | BarclaysGena Wang | $33 | 229.7% upside | |
| 2025-10-31 | Leerink PartnersMani Foroohar | $17 | 69.8% upside | |
| 2025-10-21 | RBC CapitalLisa Walter | $26 | 159.7% upside | |
| 2025-01-11 | Morgan StanleyJudah Frommer | $6 |  40.1% downside | |
| 2024-09-19 | BMO CapitalKostas Biliouris | $40 | 299.6% upside | |
| 2024-09-19 | Loop Capital MarketsGeulah Livshits | $39 | 289.6% upside | |
| 2024-09-19 | H.C. WainwrightMatthew Caufield | $36 | 259.6% upside | |
| 2024-04-15 | RBC CapitalLisa Walter | $40 | 299.6% upside | |
| 2024-04-15 | BarclaysGena Wang | $45 | 349.6% upside | |
| 2024-04-01 | JefferiesNalin Tejavibulya | $58 | 479.4% upside | |
| 2024-03-28 | BMO CapitalKostas Biliouris | $63 | 529.4% upside | |
| 2024-02-06 | BMO CapitalKostas Biliouris | $70 | 599.3% upside | |
| 2023-07-05 | Chardan CapitalGeulah Livshits | $30 | 199.7% upside | |
| 2022-11-18 | H.C. Wainwright | $36 | 259.6% upside | |
| 2022-04-05 | Evercore ISIJosh Schimmer | $40 | 299.6% upside | |